Use-Dependent Inhibition of P2X<sub>3</sub>Receptors by Nanomolar Agonist
Emily B. Pratt(Oregon Health & Science University), Sean P. Cook(University of Chicago), Pamela Bergson(University of Chicago), Thaddeus S. Brink(University of Chicago), Mark M. Voigt(Saint Louis University)
Cited by 52
Related Papers
International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits.
|PubMed|2001|635
Cloning of a putative high-affinity kainate receptor expressed predominantly in hippocampal CA3 cells
|Nature|1991|470
Hetero-oligomeric Assembly of P2X Receptor Subunits
|Journal of Biological Chemistry|1999|412
International Union of Pharmacology. XXIV. Current Status of the Nomenclature and Properties of P2X Receptors and Their Subunits
|Pharmacological Reviews|2001|386
Molecular cloning and characterization of a rat brain cDNA encoding a 5‐hydroxytryptamine1B receptor.
|The EMBO Journal|1991|217